CAS: 2225148-52-5
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Thalidomide-O-C8-Boc REF: IN-DA01V3Q7CAS: 2225148-52-5 | 95% | To inquire | Wed 13 Nov 24 | |
Thalidomide-O-C8-Boc REF: TM-T39699CAS: 2225148-52-5 | - - - | To inquire | Thu 14 Nov 24 | |
Thalidomide-o-C8-Boc REF: 3D-APD14852CAS: 2225148-52-5 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA01V3Q7
5mg | 162.00 € | ||
10mg | 182.00 € | ||
25mg | 478.00 € | ||
50mg | 533.00 € | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Wednesday 13 Nov 2024
Thalidomide-O-C8-Boc
CAS:2225148-52-5
Thalidomide-O-C8-Boc: CRBN ligand for PROTAC creation, derived from Thalidomide.
Formula:
C26H34N2O7
Color and Shape:
Solid
Molecular weight:
486.565
Ref: TM-T39699
500mg | 936.00 € | ||
1mL*10mM (DMSO) | 729.00 € |
Estimated delivery in United States, on Thursday 14 Nov 2024
Thalidomide-o-C8-Boc
CAS:2225148-52-5
Please enquire for more information about Thalidomide-o-C8-Boc including the price, delivery time and more detailed …
Formula:
C26H34N2O7
Purity:
Min. 95%
Molecular weight:
486.6 g/mol
Ref: 3D-APD14852
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |